Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
Manuel Cobo,1 Vanesa Gutiérrez,1 Rosa Villatoro,2 Jose Manuel Trigo,1 Inmaculada Ramos,1 Omar López,1 María Ruiz,1 Ana Godoy,1 Irene López,1 Macarena Arroyo3 1Medical Oncology Department, Hospital Universitario Málaga Regional y Virgen de la Vic...
Main Authors: | Cobo M, Gutiérrez V, Villatoro R, Trigo JM, Ramos I, López O, Ruiz M, Godoy A, López I, Arroyo M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-07-01
|
Series: | Lung Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-ramucirumab-in-the-treatment-of-nonsmall-cell-lung-cancer-peer-reviewed-article-LCTT |
Similar Items
-
Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer
by: Cooper MR, et al.
Published: (2016-04-01) -
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
by: De Luca E, et al.
Published: (2020-05-01) -
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
by: N. S. Besova, et al.
Published: (2021-06-01) -
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
by: Andrea Necchi, et al.
Published: (2020-11-01) -
Preclinical assessment of intravitreal ramucirumab: in vitro and in vivo safety profile
by: Jarbas Emílio de Moraes Neto, et al.
Published: (2020-09-01)